Aligos Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.74

+0.31 (+4.17%)

As of Apr 1, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target -20.0% upside

Low Target $4.22

Average Target $6.19

High Target $8.57

Current Price $7.74

Current
$7.74

Target
$6.19

$4.22 $6.19 avg $8.57

Scenario Analysis

Bear Case

$4.22

-45.5%

Low target

Base Case

$6.19

-20.0%

Avg target

Bull Case

$8.57

+10.7%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$13.69

-43.5% from high

52-Week Low

$3.76

+105.9% from low

Target vs 52W High

$6.19

-54.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%